ClinicalTrials.govpublic full text
Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia
intermediate risk chronic lymphocytic leukemia, fit patients, risk-adapted and mrd-driven strategy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 158223
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.